Nathan E. Wright
27Patents
7h-index
59Co-inventors
64Inventor score
Filing activity: Jun 30, 2016 → Sep 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9878995B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US9815818B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US10059695B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US10316017B2 | COT modulators and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US10577352B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US11066414B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US10947259B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US11325930B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US11702404B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 5 | Active |
| US10336762B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 5 | Active |
| US11858918B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 3 | Active |
| US11851419B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 3 | Active |
| US10875866B2 | Pyrrolo[1,2-B]pyridazine derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US11046686B2 | Thiadiazole IRAK4 compounds | Emerging Cross-Sectional Technologies | 2 | Active |
| US11905299B2 | Cot modulators and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11873295B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Chemistry; Metallurgy | 1 | Active |
| US11535622B2 | Pyrrolo[1,2-b] pyridazine derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US11702414B2 | Thiadiazole IRAK4 inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US12180197B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 0 | Active |
| US12060351B2 | Thiadiazole IRAK4 inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12415808B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US11572362B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12398160B2 | Cot modulators and methods of use thereof | Human Necessities | 0 | Active |
| US11053250B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12121511B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.